Intravenous immunoglobulin (IVIG)
Drug timelines are a Plus or Pro feature.
57 regulatory and trial events tracked for Intravenous immunoglobulin (IVIG), covering 2006-07-14 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]